{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:54:25Z","timestamp":1773852865253,"version":"3.50.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate chromosomal instability (CIN) in tumor tissues from transurethral resection of bladder tumor (TURBT) and evaluate its feasibility as a molecular biomarker for prognostic stratification in non-muscle-invasive bladder cancer (NMIBC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective single-center cohort study, DNA was extracted from formalin-fixed paraffin-embedded (FFPE) samples of 50 BC patients using the Qiagen nucleic acid extraction kit. The recurrence defined in this study refers to cystoscopically visible recurrence confirmed by biopsy or surgical pathology. All patients underwent follow-up until January 2025 in strict accordance with the protocol established by the EAU guidelines for NMIBC. Low-coverage whole-genome sequencing (LC-WGS) was performed to analyze CIN in bladder tumors. Time-dependent Receiver Operating Characteristic (ROC) analysis was performed to evaluate the predictive efficacy of CIN values for post-TURBT outcomes. Survival analysis was conducted using the Kaplan-Meier method (log-rank test), and associations between variables and recurrence-free survival (RFS) were assessed via Cox proportional hazards models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Recurrent bladder cancer patients exhibited significant copy number alterations (CNAs) differences in 67 gene segments versus non-recurrent patients. Time-dependent ROC analysis demonstrates that CIN values exhibit good predictive performance between the 2nd and 5th years. High CIN was significantly associated with tumor recurrence, higher tumor grade, with high-CIN patients exhibiting poorer prognosis (median RFS: 22 months vs. unreached in the low-CIN group, p = 0.009). Multivariate analysis confirmed high CIN as an independent predictor of recurrence (HR\u00a0=\u00a05.22, 95% CI: 1.52-17.93, P\u00a0=\u00a00.009). Patients with single-chromosome copy number abnormalities also showed worse outcomes (median RFS: 16\u201323 months) compared to those without such abnormalities. No significant difference in RFS was detected between Ta and T1 stages (P\u00a0=\u00a00.577).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>High CIN exhibits a correlation with bladder tumor recurrence, higher tumor grade. High CIN or the presence of specific chromosomal abnormalities are indicative of an adverse prognosis. CIN may serve as a prognostic biomarker for predicting recurrence following TURBT, particularly between the 2nd and 5th years post-surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1752078","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:37:25Z","timestamp":1773207445000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Chromosomal instability as a predictive biomarker for recurrence risk following transurethral resection of NMIBC"],"prefix":"10.3389","volume":"16","author":[{"given":"Qi","family":"Ding","sequence":"first","affiliation":[{"name":"Department of Urology, The First People\u2019s Hospital of Changshu, The Changshu Hospital Affiliated to Soochow University","place":["Changshu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailiang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Urology, The First People\u2019s Hospital of Changshu, The Changshu Hospital Affiliated to Soochow University","place":["Changshu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Urology, The First People\u2019s Hospital of Changshu, The Changshu Hospital Affiliated to Soochow University","place":["Changshu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, The First People\u2019s Hospital of Changshu, The Changshu Hospital Affiliated to Soochow University","place":["Changshu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohua","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Urology, The First People\u2019s Hospital of Changshu, The Changshu Hospital Affiliated to Soochow University","place":["Changshu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Urology, The First People\u2019s Hospital of Changshu, The Changshu Hospital Affiliated to Soochow University","place":["Changshu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First People\u2019s Hospital of Changshu, The Changshu Hospital Affiliated to Soochow University","place":["Changshu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijiang","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Urology, The First People\u2019s Hospital of Changshu, The Changshu Hospital Affiliated to Soochow University","place":["Changshu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjian","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Urology, The First People\u2019s Hospital of Changshu, The Changshu Hospital Affiliated to Soochow University","place":["Changshu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, The First People\u2019s Hospital of Changshu, The Changshu Hospital Affiliated to Soochow University","place":["Changshu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","article-title":"Advances in diagnosis and treatment of bladder cancer","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"BMJ"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European association of urology (EAU) prognostic factor risk groups for non-muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur Urol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.08.027","article-title":"The multifaceted role of chromosomal instability in cancer and its microenvironment","volume":"174","author":"Bakhoum","year":"2018","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2010.01.034","article-title":"Mechanisms of chromosomal instability","volume":"20","author":"Thompson","year":"2010","journal-title":"Curr Biol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-024-01767-7","article-title":"The two sides of chromosomal instability: drivers and brakes in cancer","volume":"9","author":"Hosea","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3390\/cancers14071749","article-title":"Elevated MACC1 expression in colorectal cancer is driven by chromosomal instability and is associated with molecular subtype and worse patient survival","volume":"14","author":"Vuaroqueaux","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e70011","DOI":"10.1002\/2056-4538.70011","article-title":"High chromosomal instability is associated with higher 10-year risks of recurrence for hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients: clinical evidence from a large-scale, multiple-site, retrospective study","volume":"10","author":"Liao","year":"2024","journal-title":"J Pathol Clin Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.hbpd.2024.03.002","article-title":"Integrated chromosomal instability and tumor microbiome redefined prognosis-related subtypes of pancreatic cancer","volume":"23","author":"Chen","year":"2024","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105896","article-title":"Identification of chromosomal instability-associated genes as hepatocellular carcinoma progression-related biomarkers to guide clinical diagnosis, prognosis and therapy","volume":"148","author":"Hu","year":"2022","journal-title":"Comput Biol Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4103\/0022-3859.123156","article-title":"Genetic instability in urinary bladder cancer: An evolving hallmark","volume":"59","author":"Wadhwa","year":"2013","journal-title":"J Postgrad Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1101\/gr.175141.114","article-title":"DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly","volume":"24","author":"Scheinin","year":"2014","journal-title":"Genome Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12920-025-02172-x","article-title":"Chromosomal instability by low-coverage whole-genome sequencing assay predicts prognosis in bladder cancer patients underwent radical cystectomy","volume":"18","author":"Ding","year":"2025","journal-title":"BMC Med Genomics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s13104-025-07306-z","article-title":"Assessing the suitability of formalin-fixed paraffin-embedded (FFPE) tissue for genome-wide association studies (GWAS)","volume":"18","author":"Reingruber","year":"2025","journal-title":"BMC Res Notes"},{"key":"B15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13073-016-0375-z","article-title":"Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue","volume":"8","author":"Kader","year":"2016","journal-title":"Genome Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"22445","DOI":"10.1038\/s41598-023-49811-w","article-title":"Association between copy number alterations estimated using low-pass whole genome sequencing of formalin-fixed paraffin-embedded prostate tumor tissue and cancer-specific clinical parameters","volume":"13","author":"Salachan","year":"2023","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1000-6702.2019.01.003","article-title":"Efficacy and complications of intravesical instillation of BCG for prevention of recurrence of moderate and high-risk non muscle invasive bladder cancer","volume":"40","author":"Sun","year":"2019","journal-title":"Chin J Urol"},{"key":"B18","article-title":"WMA Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Participants","volume-title":"75th WMA General Assembly","year":"2024"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2018.29.e78","article-title":"Using low-coverage whole genome sequencing technique to analyze the chromosomal copy number alterations in the exfoliative cells of cervical cancer","volume":"29","author":"Ren","year":"2018","journal-title":"J Gynecol Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-0401","article-title":"Noninvasive detection of urothelial carcinoma by cost-effective low-coverage whole-genome sequencing from urine-exfoliated cell DNA","volume":"26","author":"Zeng","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"690","DOI":"10.4251\/wjgo.v14.i3.690","article-title":"Cost-effective low-coverage whole-genome sequencing assay for the risk stratification of gastric cancer","volume":"14","author":"Ye","year":"2022","journal-title":"World J Gastrointest Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2013.02.001","article-title":"2n or not 2n: Aneuploidy, polyploidy and chromosomal instability in primary and tumor cells","volume":"24","author":"Zasadil","year":"2013","journal-title":"Semin Cell Dev Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2021.01.004","article-title":"Causes and consequences of micronuclei","volume":"70","author":"Krupina","year":"2021","journal-title":"Curr Opin Cell Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrg3123","article-title":"Causes and consequences of aneuploidy in cancer","volume":"13","author":"Gordon","year":"2012","journal-title":"Nat Rev Genet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","article-title":"Genomic and functional approaches to understanding cancer aneuploidy","volume":"33","author":"Taylor","year":"2018","journal-title":"Cancer Cell"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4405","article-title":"Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence","volume":"23","author":"Goh","year":"2017","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cell.2018.03.057","article-title":"Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal","volume":"173","author":"Turajlic","year":"2018","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12920-022-01253-5","article-title":"Copy number variation of urine exfoliated cells by low-coverage whole genome sequencing for diagnosis of prostate adenocarcinoma: a prospective cohort study","volume":"15","author":"Guan","year":"2022","journal-title":"BMC Med Genomics"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-4608(01)00618-5","article-title":"Numerical aberrations of chromosome 9 in bladder cancer. A possible prognostic marker for early tumor recurrence","volume":"134","author":"Tsukamoto","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204022","article-title":"Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest","volume":"19","author":"Simoneau","year":"2000","journal-title":"Oncogene"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700068","article-title":"Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer","volume":"84","author":"Stoehr","year":"2004","journal-title":"Lab Invest"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1089\/104454902760599681","article-title":"KIAA1096, a gene on chromosome 1q, is amplified and overexpressed in bladder cancer","volume":"21","author":"Huang","year":"2002","journal-title":"DNA Cell Biol"},{"key":"B33","article-title":"Ki-67 fraction, p53 alteration and numerical chromosome aberrations (chromosomes 7 and 17) in formalin fixed bladder tumors","volume":"77","author":"Moch","year":"1993","journal-title":"Verh Dtsch Ges Pathol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.2000.00326.x","article-title":"Aneusomy of chromosomes 7 and 17 predicts the recurrence of transitional cell carcinoma of the urinary bladder","volume":"85","author":"Watters","year":"2000","journal-title":"BJU Int"},{"key":"B35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskjot","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5259602","article-title":"Prognostic and clinicopathological significance of downregulated p16 expression in patients with bladder cancer: A systematic review and meta-analysis","volume":"2016","author":"Gan","year":"2016","journal-title":"Dis Markers"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e675","DOI":"10.1002\/ctm2.675","article-title":"METTL1-m(7) G-EGFR\/EFEMP1 axis promotes the bladder cancer development","volume":"11","author":"Ying","year":"2021","journal-title":"Clin Transl Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-01794-7","article-title":"SBSN drives bladder cancer metastasis via EGFR\/SRC\/STAT3 signalling","volume":"127","author":"Zhou","year":"2022","journal-title":"Br J Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2023.07.014","article-title":"Field cancerization is associated with tumor development, T-cell exhaustion, and clinical outcomes in bladder cancer","volume":"85","author":"Strandgaard","year":"2024","journal-title":"Eur Urol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2396559","article-title":"Chromosomal instability is associated with prognosis and efficacy of bevacizumab after resection of colorectal cancer liver metastasis","volume":"56","author":"Li","year":"2024","journal-title":"Ann Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"106 e117","DOI":"10.1016\/j.urolonc.2022.10.002","article-title":"Chromosome 8q arm overexpression is associated with worse prostate cancer prognosis","volume":"41","author":"Alshalalfa","year":"2023","journal-title":"Urol Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s10577-020-09638-x","article-title":"Genomic and epigenetic aberrations of chromosome 1p36.13 have prognostic implications in Malignancies","volume":"28","author":"Naderi","year":"2020","journal-title":"Chromosome Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0247169","DOI":"10.1371\/journal.pone.0247169","article-title":"Downregulation of PAICS due to loss of chromosome 4q is associated with poor survival in stage III colorectal cancer","volume":"16","author":"Kobayashi","year":"2021","journal-title":"PloS One"},{"key":"B44","first-page":"13","article-title":"Identification of hub genes and pathways in bladder cancer using bioinformatics analysis","volume":"10","author":"Li","year":"2022","journal-title":"Am J Clin Exp Urol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/path.5274","article-title":"YWHAZ amplification\/overexpression defines aggressive bladder cancer and contributes to chemo-\/radio-resistance by suppressing caspase-mediated apoptosis","volume":"248","author":"Yu","year":"2019","journal-title":"J Pathol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14321","article-title":"p62 promotes bladder cancer cell growth by activating KEAP1\/NRF2-dependent antioxidative response","volume":"111","author":"Li","year":"2020","journal-title":"Cancer Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-1531","article-title":"The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease","volume":"74","author":"Fu","year":"2014","journal-title":"Cancer Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1752078\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:25:51Z","timestamp":1773829551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1752078\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":47,"alternative-id":["10.3389\/fonc.2026.1752078"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1752078","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"article-number":"1752078"}}